Status: current, Primitive. Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4623745012 | Daclatasvir dihydrochloride (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4623746013 | Daclatasvir dihydrochloride | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclatasvir dihydrochloride | Is a | Hepatitis C virus protein NS5A inhibitor | true | Inferred relationship | Some | ||
| Daclatasvir dihydrochloride | Has disposition | Hepatitis C virus protein NS5A inhibitor | true | Inferred relationship | Some | ||
| Daclatasvir dihydrochloride | Is modification of | Daclatasvir | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Daclatasvir (as daclatasvir dihydrochloride) 60 mg oral tablet | Has precise active ingredient | True | Daclatasvir dihydrochloride | Inferred relationship | Some | 1 |
| Daclatasvir (as daclatasvir dihydrochloride) 30 mg oral tablet | Has precise active ingredient | True | Daclatasvir dihydrochloride | Inferred relationship | Some | 1 |
| Daclatasvir (as daclatasvir dihydrochloride) 90 mg oral tablet | Has precise active ingredient | True | Daclatasvir dihydrochloride | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR